MUMBAI, India, Sept. 14 -- Intellectual Property India has published a patent application (202617064637 A) filed by Hansoh Bio LLC; Shanghai Hansoh Biomedical Co. , Ltd.; and Changzhou Hansoh Pharmaceutical Co. , Ltd. on May 22, 2026, for Ligand-Cytotoxicity Drug Conjugates And Pharmaceutical Uses Thereof.
Inventors include Li, Qing; and Zhou, Ningyun.
The application for the patent was published on September 11, 2026, under issue no. 37/2026.
Abstract: To provide an antitumor drug having an excellent therapeutic effect, which is excellent in terms of antitumor effect and safety. Provided is an anti-cadherin 17 antibody comprising a heavy chain variable region and a light chain variable region, a drug conjugate thereof, and a composition...